Mucoepidermoid carcinoma surgery

Jump to: navigation, search

Mucoepidermoid carcinoma Microchapters


Patient Information


Historical Perspective




Differentiating Mucoepidermoid Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis



History and Symptoms

Physical Examination

Laboratory Findings

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucoepidermoid carcinoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Mucoepidermoid carcinoma surgery

All Images
Echo and Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucoepidermoid carcinoma surgery

CDC on Mucoepidermoid carcinoma surgery

Mucoepidermoid carcinoma surgery in the news

Blogs on Mucoepidermoid carcinoma surgery

Directions to Hospitals Treating Mucoepidermoid carcinoma

Risk calculators and risk factors for Mucoepidermoid carcinoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] , Maria Fernanda Villarreal, M.D. [3]


Surgery is the mainstay of therapy for mucoepidermoid carcinoma.


  • Mucoepidermoid carcinoma (low-grade): complete surgical excision with sparing of the facial nerve.[1][1]
  • Mucoepidermoid carcinoma (high-grade): parotidectomy with facial nerve sparing may be followed by radiotherapy.
  • Clinically aggressive mucoepidermoid carcinoma tumors with facial nerve involvement will require radical surgery with sacrifice of the facial nerve and radiotherapy. [2]
  • Primary nerve grafting using the sural nerve if possible is performed.
  • Lymph node dissection is usually only performed for detected nodal metastasis.
  • Low grade mucoepidermoid carcinoma in the floor of the mouth can be surgically excised along with involved lymph node.[3][4]
  • When the tumor is at an inaccessible location, clinical trial therapies (especially for stage IV disease) including:
    • Therapeutic drugs
    • Radiation
    • Stem cell transplantation
    • Monoclonal antibodies
  • Either singly or in combination of various therapies
  • Follow-up care with regular screening and check-ups are important[5]


  • Indications for surgery for mucoepidermoid carcinoma, include:[6]
  • Biological and histological features suitable for surgery



  1. 1.0 1.1 Mucoepidermoid Carcinoma Surgery. WikiBooks. Accessed on February 17,2016
  2. Gedar Totuk OM, Demir MK, Yapicier O, Mestanoglu M (2017). "Low-Grade Mucoepidermoid Carcinoma of the Lacrimal Gland in a Teenaged Patient". Case Rep Ophthalmol Med. 2017: 2418505. doi:10.1155/2017/2418505. PMC 5727657. PMID 29318070.
  3. Rinaldo A, Shaha AR, Pellitteri PK, Bradley PJ, Ferlito A (January 2004). "Management of malignant sublingual salivary gland tumors". Oral Oncol. 40 (1): 2–5. PMID 14662408.
  4. Helmus C (August 1997). "Subtotal parotidectomy: a 10-year review (1985 to 1994)". Laryngoscope. 107 (8): 1024–7. PMID 9261001.
  5. Maloth AK, Nandan SR, Kulkarni PG, Dorankula SP, Muddana K (December 2015). "Mucoepidermoid Carcinoma of Floor of the Mouth - A Rarity". J Clin Diagn Res. 9 (12): ZD03–4. doi:10.7860/JCDR/2015/15595.6912. PMC 4717804. PMID 26813873.
  6. Rapidis, Alexander D.; Givalos, Nikolaos; Gakiopoulou, Hariklia; Stavrianos, Spyros D.; Faratzis, Gregory; Lagogiannis, George A.; Katsilieris, Ioannis; Patsouris, Efstratios (2007). "Mucoepidermoid carcinoma of the salivary glands". Oral Oncology. 43 (2): 130–136. doi:10.1016/j.oraloncology.2006.03.001. ISSN 1368-8375.